Objective To systematically review the efficacy of multiple doses and single dose of perioperative dexamethasone on pain and recovery after total knee arthroplasty (TKA).
Methods PubMed, Embase, Cochrane Library, Web of Science, CNKI, WanFang Data, SinoMed and VIP databases were electronically searched to collect randomized controlled trials (RCTs) on multiple doses and single dose of dexamethasone during perioperative period of TKA from inception of the databases to January 4, 2024. Two reviewers independently screened the literature, extracted data and assessed the risk of bias of the included studies. Meta-analysis was performed by using RevMan 5.4 software.
Results A total of 6 studies involving 674 patients were included, 336 patients in single dose dexamethasone group and 338 patients in multiple dose dexamethasone group. The results of Meta-analysis showed that compared with single dose of dexamethasone, multiple doses of perioperative dexamethasone could significantly decrease the pain scores at rest at 48 h after TKA (SMD=-0.68, 95%CI -1.05 to -0.30, P﹤0.001), the pain scores with movement at postoperative 48 h (SMD= -0.86, 95%CI -1.37 to -0.34, P=0.001), C-reactive protein (CRP) levels at postoperative 48 h (MD=- 4.43, 95%CI -6.70 to -2.16, P ﹤ 0.001) and CRP levels at postoperative 72 h (MD= -3.60, 95%CI -5.53 to -1.67, P ﹤ 0.001). There was no statistically significant difference between the two groups regarding pain scores at rest at postoperative 24 h and 72 h, pain scores with movement at postoperative 24 h and 72 h, incidence of postoperative nausea and vomiting (PONV), CRP levels at postoperative 24 h, length of hospital stay, and incidence of adverse drug reactions (P>0.05). The results of 5 studies showed that multiple doses of dexamethasone did not increase the dosage or patient proportion of remedial analgesics.
Conclusion Current evidence shows that compared with single dose of dexamethasone, multiple doses of perioperative dexamethasone can significantly reduce pain scores at postoperative 48 h, CRP levels at postoperative 48 and 72 h after TKA, but it does not significantly reduce the incidence of PONV, hospital stay, or increase the risk of adverse drug reactions.
1.Zhao C, Wang L, Chen L, et al. Effects of magnesium sulfate on periarticular infiltration analgesia in total knee arthroplasty: a prospective, double-blind, randomized controlled trial[J]. J Orthop Surg Res, 2023, 18(1): 301. DOI: 10.1186/s13018-023-03790-w.
2.杨琳, 杨志英. ERAS协会“髋/膝关节置换术围术期加速康复护理共识”解读[J]. 护理研究, 2021, 35(11): 1881-1885. [Yang L, Yang ZY. Interpretation of "consensus statement for perioperative care in total hip replacement and total knee replacement surgery: Enhanced Recovery After Surgery Society recommendations"[J]. Chinese Nursing Research, 2021, 35(11): 1881-1885.] DOI: 10.12102/j.issn.1009-6493.2021.11.001.
3.Elmallah RK, Chughtai M, Khlopas A, et al. Pain control in total knee arthroplasty[J]. J Knee Surg, 2018, 31(6): 504-513. DOI: 10.1055/s-0037-1604152.
4.Aroke EN, Hicks TL. Pharmacogenetics of postoperative nausea and vomiting[J]. J Perianesth Nurs, 2019, 34(6): 1088-1105. DOI: 10.1016/j.jopan.2019.03.007.
5.Van de Velde M, Bonnet F, Pogatzki-Zahn E. High dose glucocorticoids: will this change the face of multimodal postoperative analgesia and enhanced recovery?[J]. Eur J Anaesthesiol, 2023, 40(3): 151-152. DOI: 10.1097/EJA.0000000000001782.
6.Yoshida B, Piple AS, Wang JC, et al. Perioperative dexamethasone associated with decreased length of stay after total hip and knee arthroplasty[J]. J Am Acad Orthop Surg, 2023, 31(19): e778-e787. DOI: 10.5435/JAAOS-D-22-01146.
7.Stambough JB, Beaulé PE, Nunley RM, et al. Contemporary strategies for rapid recovery total hip arthroplasty[J]. Instr Course Lect, 2016, 65: 211-224. https://pubmed.ncbi.nlm.nih.gov/27049192/.
8.De Oliveira GS Jr, Almeida MD, Benzon HT, et al. Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials[J]. Anesthesiology, 2011, 115(3): 575-588. DOI: 10.1097/ALN.0b013e31822a24c2.
9.Kim JK, Ro DH, Lee HJ, et al. Efficacy of systemic steroid use given one day after total knee arthroplasty for pain and nausea: a randomized controlled study[J]. J Arthroplasty, 2020, 35(1): 69-75. DOI: 10.1016/j.arth.2019.08.026.
10.De Luca ML, Ciccarello M, Martorana M, et al. Pain monitoring and management in a rehabilitation setting after total joint replacement[J]. Medicine (Baltimore), 2018, 97(40): e12484. DOI: 10.1097/MD.0000000000012484.
11.周宗科, 翁习生, 曲铁兵, 等. 中国髋、膝关节置换术加速康复——围术期管理策略专家共识[J]. 中华骨与关节外科杂志, 2016, 9(1): 1-9. [Zhou ZK, Weng XS, Qu TB, et al. Expert consensus in enhanced recovery after total hip and knee arthroplasty in China: perioperative management[J]. Chinese Journal Bone and Joint Surgery, 2016, 9(1): 1-9.] DOI: 10.3969/j.issn.2095-9985.2016.01.001.
12.Short TG, Leslie K. Dexamethasone-an effective antiemetic, but is it safe?[J]. Anaesth Intensive Care, 2015, 43(2): 155-156. DOI: 10.1177/0310057X1504300203.
13.李柄辉, 訾豪, 李路遥, 等. 医学领域一次研究和二次研究的方法学质量(偏倚风险)评价工具[J]. 医学新知, 2021, 31(1): 51-58. [Li BH, Zi H, Li LY, et al. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?[J]. Yixue Xinzhi Zazhi, 2021, 31(1): 51-58.] DOI: 10.12173/j.issn.1004-5511.2021.01.07.
14.潘相丞, 倪晓凤, 彭容, 等. 中国儿童吸入用布地奈德混悬液使用情况的系统评价和Meta分析[J]. 药物流行病学杂志, 2023, 32(10): 1144-1157. [Pan XC, Ni XF, Peng R, et al. Usage of budesonide suspension for inhalation in Chinese children:a systematic review and Meta-analysis[J]. Chinese Journal of Pharmacoepidemiology, 2023, 32(10): 1144-1157.] DOI: 10.19960/j.issn.1005-0698.202310008.
15.李雨芯, 熊俊, 张政, 等. 中药系统评价/Meta分析报告规范(PRISMA-CHM)解读[J]. 中国循证医学杂志, 2023, 23(11): 1351-1359. [Li YX, Xiong J, Zhang Z, et al. Interpretation of the PRISMA extension for Chinese herbal medicine review (PRISMA-CHM)[J]. Chinese Journal of Evidence-Based Medicine, 2023, 23(11): 1351-1359.] DOI: 10.7507/1672-2531.202303057.
16.曾保起, 章萌, 刘晓智, 等. 多烯磷脂酰胆碱注射液治疗酒精性肝病的系统评价与Meta分析[J]. 中国药师, 2024, 27(1): 135-144. [Zeng BQ, Zhang M, Liu XZ, et al. Polyene phosphatidylcholine injection in the treatment of alcoholic liver disease:a systematic review and Meta-analysis[J]. China Pharmacist, 2024, 27(1): 135-144.] DOI: 10.12173/j.issn.1008-049X.202310125.
17.Wu Y, Lu X, Ma Y, et al. Perioperative multiple low-dose Dexamethasones improves postoperative clinical outcomes after total knee arthroplasty[J]. BMC Musculoskelet Disord, 2018, 19(1): 428. DOI: 10.1186/s12891-018-2359-1.
18.Xu H, Zhang S, Xie J, et al. Multiple doses of perioperative dexamethasone further improve clinical outcomes after total knee arthroplasty: a prospective, randomized, controlled study[J]. J Arthroplasty, 2018, 33(11): 3448-3454. DOI: 10.1016/j.arth.2018.06.031.
19.周明. 静脉应用地塞米松对TKA术后快速康复的有效性及安全性研究[D]. 山东青岛: 青岛大学, 2018.
20.Gasbjerg KS, Hägi-Pedersen D, Lunn TH, et al. Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial[J]. BMJ, 2022, 376: e067325.
21.李聪. 地塞米松在人工关节置换术后加速康复外科中的应用研究[D]. 兰州: 西北民族大学, 2022.
22.Derby CB, Gasbjerg KS, Hägi-Pedersen D, et al. Prolonged effects of dexamethasone following total knee arthroplasty: a pre-planned sub-study of the DEX-2-TKA trial[J]. Acta Anaesthesiol Scand, 2024, 68(1): 35-42. DOI: 10.1111/aas.14319.
23.Theis KA, Murphy LB, Guglielmo D, et al. Prevalence of arthritis and arthritis-attributable activity limitation - United States, 2016-2018[J]. MMWR Morb Mortal Wkly Rep, 2021, 70(40): 1401-1407. DOI: 10.15585/mmwr.mm7040a2.
24.Tarasov DA, Lychagin AV, Yavorovkiy AG, et al. C-reactive protein as marker of post-operative analgesic quality after primary total knee arthroplasty[J]. Int Orthop, 2020, 44(9): 1727-1735. DOI: 10.1007/s00264-020-04551-8.
25.Samona J, Cook C, Krupa K, et al. Effect of intraoperative dexamethasone on pain scores and narcotic consumption in patients undergoing total knee arthroplasty[J]. Orthop Surg, 2017, 9(1): 110-114. DOI: 10.1111/os.12313.
26.Snäll J, Törnwall J, Suominen AL, et al. Behavior of C-reactive protein in association with surgery of facial fracture and the influence of dexamethasone[J]. Oral Maxillofac Surg, 2018, 22(2): 129-134. DOI: 10.1007/s10006-018-0678-x.
27.Hannon CP, Fillingham YA, Mason JB, et al. The efficacy and safety of corticosteroids in total joint arthroplasty: a direct Meta-analysis[J]. J Arthroplasty, 2022, 37(10): 1898-1905.e7. DOI: 10.1016/j.arth.2022.03.084.
28.Lavand'homme P, Kehlet H. Benefits versus harm of intraoperative glucocorticoid for postoperative nausea and vomiting prophylaxis[J]. Br J Anaesth, 2023, 131(1): 8-10. DOI: 10.1016/j.bja.2023.04.013.